SUSMITHA APURI M.D NPI 1154598068

NPI Information

  • NPI: 1154598068
  • Provider Name: SUSMITHA APURI, M.D
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2231 HIGHWAY 44 W STE 203
    INVERNESS, FL
    ZIP 34453
  • Phone: (352) 860-7400

Map and Directions

Get Directions

NPI Details

Susmitha Apuri, M.D is a medical oncology internal medicine in Inverness, FL with 22 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Susmitha Apuri, M.D NPI is 1154598068. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2231 HIGHWAY 44 W STE 203
INVERNESS, FL
ZIP 34453
Phone: (352) 860-7400

The NPI 1154598068 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron binding capacity (HCPCS:83550)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Magnesium level (HCPCS:83735)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Blood test, clotting time (HCPCS:85610)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Protein measurement, serum (HCPCS:84165)
  • Automated urinalysis test (HCPCS:81003)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Folic acid level, serum (HCPCS:82746)
  • Red blood count automated, with additional calculations (HCPCS:85046)

The enumeration date for this NPI number is 5/9/2008 and was last updated on 8/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME109206FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME109206FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1003482400MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.